151 related articles for article (PubMed ID: 23055731)
41. Investigation of siRNA-loaded polyethylenimine-coated human serum albumin nanoparticle complexes for the treatment of breast cancer.
Abbasi S; Paul A; Prakash S
Cell Biochem Biophys; 2011 Nov; 61(2):277-87. PubMed ID: 21556941
[TBL] [Abstract][Full Text] [Related]
42. Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery.
Li J; Chen YC; Tseng YC; Mozumdar S; Huang L
J Control Release; 2010 Mar; 142(3):416-21. PubMed ID: 19919845
[TBL] [Abstract][Full Text] [Related]
43. In vitro-in vivo translation of lipid nanoparticles for hepatocellular siRNA delivery.
Whitehead KA; Matthews J; Chang PH; Niroui F; Dorkin JR; Severgnini M; Anderson DG
ACS Nano; 2012 Aug; 6(8):6922-9. PubMed ID: 22770391
[TBL] [Abstract][Full Text] [Related]
44. Chemical modification of chitosan with pH-sensitive molecules and specific ligands for efficient DNA transfection and siRNA silencing.
Singh B; Choi YJ; Park IK; Akaike T; Cho CS
J Nanosci Nanotechnol; 2014 Jan; 14(1):564-76. PubMed ID: 24730283
[TBL] [Abstract][Full Text] [Related]
45. Influence of nano-carrier architecture on in vitro siRNA delivery performance and in vivo biodistribution: polyplexes vs micelleplexes.
Gary DJ; Lee H; Sharma R; Lee JS; Kim Y; Cui ZY; Jia D; Bowman VD; Chipman PR; Wan L; Zou Y; Mao G; Park K; Herbert BS; Konieczny SF; Won YY
ACS Nano; 2011 May; 5(5):3493-505. PubMed ID: 21456626
[TBL] [Abstract][Full Text] [Related]
46. Multifunctional polyamidoamine-modified selenium nanoparticles dual-delivering siRNA and cisplatin to A549/DDP cells for reversal multidrug resistance.
Zheng W; Cao C; Liu Y; Yu Q; Zheng C; Sun D; Ren X; Liu J
Acta Biomater; 2015 Jan; 11():368-80. PubMed ID: 25204523
[TBL] [Abstract][Full Text] [Related]
47. Solid nano-in-nanoparticles for potential delivery of siRNA.
Amsalem O; Nassar T; Benhamron S; Lazarovici P; Benita S; Yavin E
J Control Release; 2017 Jul; 257():144-155. PubMed ID: 27215702
[TBL] [Abstract][Full Text] [Related]
48. Mesoporous silica nanoparticles facilitate delivery of siRNA to shutdown signaling pathways in mammalian cells.
Hom C; Lu J; Liong M; Luo H; Li Z; Zink JI; Tamanoi F
Small; 2010 Jun; 6(11):1185-90. PubMed ID: 20461725
[No Abstract] [Full Text] [Related]
49. Enhanced siRNA delivery and silencing gold-chitosan nanosystem with surface charge-reversal polymer assembly and good biocompatibility.
Han L; Zhao J; Zhang X; Cao W; Hu X; Zou G; Duan X; Liang XJ
ACS Nano; 2012 Aug; 6(8):7340-51. PubMed ID: 22838646
[TBL] [Abstract][Full Text] [Related]
50. Target-specific delivery of siRNA by stabilized calcium phosphate nanoparticles using dopa-hyaluronic acid conjugate.
Lee MS; Lee JE; Byun E; Kim NW; Lee K; Lee H; Sim SJ; Lee DS; Jeong JH
J Control Release; 2014 Oct; 192():122-30. PubMed ID: 24995950
[TBL] [Abstract][Full Text] [Related]
51. Targeting the blind spot of polycationic nanocarrier-based siRNA delivery.
Zheng M; Pavan GM; Neeb M; Schaper AK; Danani A; Klebe G; Merkel OM; Kissel T
ACS Nano; 2012 Nov; 6(11):9447-54. PubMed ID: 23036046
[TBL] [Abstract][Full Text] [Related]
52. Cationic nanostructured polymers for siRNA delivery in murine calvarial pre-osteoblasts.
Hsu EW; Liu S; Shrivats AR; Watt AC; McBride S; Averick SE; Cho HY; Matyjaszewski K; Hollinger JO
J Biomed Nanotechnol; 2014 Jun; 10(6):1130-6. PubMed ID: 24749407
[TBL] [Abstract][Full Text] [Related]
53. Silencing of GFP expression in human mesenchymal stem cells using quaternary polyplexes of siRNA-PEI with glycosaminoglycans and albumin.
Herrera LC; Shastri VP
Acta Biomater; 2019 Nov; 99():397-411. PubMed ID: 31541736
[TBL] [Abstract][Full Text] [Related]
54. Smart multilayered assembly for biocompatible siRNA delivery featuring dissolvable silica, endosome-disrupting polycation, and detachable PEG.
Suma T; Miyata K; Anraku Y; Watanabe S; Christie RJ; Takemoto H; Shioyama M; Gouda N; Ishii T; Nishiyama N; Kataoka K
ACS Nano; 2012 Aug; 6(8):6693-705. PubMed ID: 22835034
[TBL] [Abstract][Full Text] [Related]
55. Hydrophobic scaffolds of pH-sensitive cationic lipids contribute to miscibility with phospholipids and improve the efficiency of delivering short interfering RNA by small-sized lipid nanoparticles.
Sato Y; Okabe N; Note Y; Hashiba K; Maeki M; Tokeshi M; Harashima H
Acta Biomater; 2020 Jan; 102():341-350. PubMed ID: 31733331
[TBL] [Abstract][Full Text] [Related]
56. Human serum albumin-coated lipid nanoparticles for delivery of siRNA to breast cancer.
Piao L; Li H; Teng L; Yung BC; Sugimoto Y; Brueggemeier RW; Lee RJ
Nanomedicine; 2013 Jan; 9(1):122-9. PubMed ID: 22542825
[TBL] [Abstract][Full Text] [Related]
57. Nanosac, a Noncationic and Soft Polyphenol Nanocapsule, Enables Systemic Delivery of siRNA to Solid Tumors.
Kim H; Yuk SA; Dieterly AM; Kwon S; Park J; Meng F; Gadalla HH; Cadena MJ; Lyle LT; Yeo Y
ACS Nano; 2021 Mar; 15(3):4576-4593. PubMed ID: 33645963
[TBL] [Abstract][Full Text] [Related]
58. Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells.
Basha G; Novobrantseva TI; Rosin N; Tam YY; Hafez IM; Wong MK; Sugo T; Ruda VM; Qin J; Klebanov B; Ciufolini M; Akinc A; Tam YK; Hope MJ; Cullis PR
Mol Ther; 2011 Dec; 19(12):2186-200. PubMed ID: 21971424
[TBL] [Abstract][Full Text] [Related]
59. Lipid-based siRNA Delivery Systems: Challenges, Promises and Solutions Along the Long Journey.
Sarisozen C; Salzano G; Torchilin VP
Curr Pharm Biotechnol; 2016; 17(8):728-40. PubMed ID: 27033509
[TBL] [Abstract][Full Text] [Related]
60. Biodegradable nanocapsules as siRNA carriers for mutant K-Ras gene silencing of human pancreatic carcinoma cells.
Lin G; Hu R; Law WC; Chen CK; Wang Y; Li Chin H; Nguyen QT; Lai CK; Yoon HS; Wang X; Xu G; Ye L; Cheng C; Yong KT
Small; 2013 Aug; 9(16):2757-63. PubMed ID: 23427041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
